NDC 0409-2045 – Milrinone Lactate in Dextrose
Milrinone Lactate .2 mg/mL · Injection, Solution · Intravenous
Product NDC0409-2045
Product details
- Brand name
- Milrinone Lactate in Dextrose
- Generic name
- Milrinone Lactate in Dextrose
- Labeler
- Hospira, Inc.
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- ANDA · ANDA213585
- Marketed since
- April 4, 2022
- Listing expires
- December 31, 2026
- Pharmacologic class
- Phosphodiesterase 3 Inhibitor
Active ingredients
- Milrinone Lactate .2 mg/mL
Uses, dosage, side effects and warnings for Milrinone Lactate in Dextrose →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0409-2045-10 | 10 POUCH in 1 CARTON (0409-2045-10) / 1 BAG in 1 POUCH (0409-2045-01) / 100 mL in 1 BAG | Apr 4, 2022 |
Other Milrinone Lactate in Dextrose products
- 0338-6010 Milrinone Lactate .2 mg/mL · Injection, Solution · Baxter Healthcare Corporation
- 0338-6011 Milrinone Lactate .2 mg/mL · Injection, Solution · Baxter Healthcare Corporation
- 68083-410 Milrinone Lactate .2 mg/mL · Injection, Solution · Gland Pharma Limited
- 68083-411 Milrinone Lactate .2 mg/mL · Injection, Solution · Gland Pharma Limited
- 0143-9718 Milrinone Lactate 200 ug/mL · Injection, Solution · Hikma Pharmaceuticals USA Inc.
- 0143-9719 Milrinone Lactate 200 ug/mL · Injection, Solution · Hikma Pharmaceuticals USA Inc.
- 0409-1983 Milrinone Lactate .2 mg/mL · Injection, Solution · Hospira, Inc.
- 25021-313 Milrinone Lactate .2 mg/mL · Injection, Solution · Sagent Pharmaceuticals